Does RIBOFLAVIN Cause Hyperlipidaemia? 74 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Hyperlipidaemia have been filed in association with RIBOFLAVIN. This represents 8.7% of all adverse event reports for RIBOFLAVIN.
74
Reports of Hyperlipidaemia with RIBOFLAVIN
8.7%
of all RIBOFLAVIN reports
27
Deaths
73
Hospitalizations
How Dangerous Is Hyperlipidaemia From RIBOFLAVIN?
Of the 74 reports, 27 (36.5%) resulted in death, 73 (98.6%) required hospitalization, and 27 (36.5%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOFLAVIN. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOFLAVIN Cause?
Off label use (410)
Drug ineffective (372)
Nausea (271)
Drug hypersensitivity (270)
Product use in unapproved indication (265)
Pain (264)
Infusion related reaction (225)
Swelling (223)
Sleep disorder (214)
Pericarditis (210)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which RIBOFLAVIN Alternatives Have Lower Hyperlipidaemia Risk?
RIBOFLAVIN vs RIBOFLAVIN 5'-PHOSPHATE
RIBOFLAVIN vs RIBOFLAVIN 5^-PHOSPHATE
RIBOFLAVIN vs RIFABUTIN
RIBOFLAVIN vs RIFAMPICIN
RIBOFLAVIN vs RIFAMPIN